REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1627 Ex Parte Garcia-Rill 11716218 - (D) JENKS 103 MCTAVISH PATENT FIRM CARTER, KENDRA D
1644 Ex Parte Keler et al 10903191 - (D) JENKS 103 NELSON MULLINS RILEY & SCARBOROUGH LLP KIM, YUNSOO
Tech Center 2100 Computer Architecture and Software
2174 Ex Parte Mathews et al 12784589 - (D) McGRAW 103 VERIZON TILLERY, RASHAWN N
Tech Center 2600 Communications
2657 Ex Parte Ho 12973737 - (D) NAPPI 102/103 SUGHRUE MION, PLLC ALBERTALLI, BRIAN LOUIS
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3741 Ex Parte Porte et al 12307886 - (D) REIMERS 103 Dickinson Wright PLLC SUNG, GERALD LUTHER
3763 Ex Parte Norman et al 12196777 - (D) HARLOW 102/103 DICKE, BILLIG & CZAJA, PLLC MDT SURGICAL TECHNOLOGIES MATTERS BOSQUES, EDELMIRA
AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1611 Ex Parte Johnson et al 10719007 - (D) PRATS 103 103 Bozicevic, Field & Francis BFF/Durect Corporation GHALI, ISIS A D
As to commercially available sufentanil compositions (Br. 17), our reviewing court has explained that “[n]othing in the statute or our case law requires [the proponent] to prove obviousness by starting with a prior art commercial embodiment and then providing motivation to alter that commercial embodiment.” Galderma Labs., L.P. v. Tolmar, Inc., 737 F.3d 731, 737 (Fed. Cir. 2013).
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1618 Ex Parte Waldron et al 11499044 - (D) ADAMS 112(1)/102/103 POTTER ANDERSON & CORROON LLP EBRAHIM, NABILA G
Tech Center 1700 Chemical & Materials Engineering
1747 Ex Parte Mariani et al 12448304 - (D) DELMENDO 103 FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP ROGERS, MARTIN K
1785 Ex Parte Rivkin et al 12427534 - (D) SMITH 112(1) 112(1)/102/103 Hollingsworth Davis BERNATZ, KEVIN M
1788 Ex Parte Wagner et al 11516956 - (D) FRANKLIN 102/103 NOVAK DRUCE CONNOLLY BOVE + QUIGG LLP CHANG, VICTOR S
Gates’ stated preference for a fluid matrix does not teach away from an elastomer or soft plastic matrix, which are expressly disclosed alternatives. Galderma Labs., L.P. v. Tolmar, Inc., 737 F.3d 731, 738 (Fed. Cir. 2013), cert. denied, 134 S. Ct. 2740 (U.S. 2014) (“A reference does not teach away, . . . if it merely expresses a general preference for an alternative invention but does not criticize, discredit, or otherwise discourage investigation into the invention claimed.”)
Tech Center 2100 Computer Architecture and Software
2143 Ex Parte Best 12199523 - (D) DIXON 101 102/103 CRGO LAW PILLAI, NAMITHA
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2427 Ex Parte KAN et al 11876110 - (D) FINK 103 RGIP LLC KURIEN, CHRISTEN A
2467 Ex Parte Lopes 12466005 - (D) LENTIVECH 103 Faegre Baker Daniels LLP GOOGLE SHARMA, GAUTAM
2497 Ex Parte Da Silva Neto 10518545 - (D) HAAPALA 103 BACON & THOMAS, PLLC WRIGHT, BRYAN F
Tech Center 2600 Communications
2688 Ex Parte Annampedu et al 12328024 - (D) BAER 103 LSI CORPORATION NEGRON, DANIELL L
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte McKay et al 11873905 - (D) FETTING 103 CANTOR COLBURN LLP-IBM YORKTOWN ANDERSON, FOLASHADE
3626 Ex Parte St. Clair et al 11493922 - (D) LORIN 103 BLANK ROME LLP REYES, REGINALD R
3683 Ex Parte Ross et al 12201986 - (D) FETTING 101/102/103 41.50 101/103 LEYDIG VOIT & MAYER, LTD NGUYEN, NGA B
REEXAMINATION
AFFIRMED-IN-PART
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2863 STRAVA, INC., MAPMYFITNESS, INC., and FITNESSKEEPER, INC. Requester, v. ICON HEALTH & FITNESS, INC. Patent Owner Ex Parte 6701271 et al 09/859,827 95002337 - (D) McKEOWN 112(2)/102/103 102/103 41.77 103 Maschoff Brennan FOR THIRD-PARTY REQUESTER: Sterne Kessler Goldstein & Fox, PLLC NGUYEN, MINH T original BUI, BRYAN
